• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

gene editing

Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together
MedTech

Genomics inks deal with Greywolf to assess gene datasets

Genomics inked a partnership deal with Greywolf Therapeutics to organize and evaluate ERAP enzymes and how they influence autoimmune disease risks.
Joseph Keenan May 1, 2026 8:18am
An illustration of a white strand of DNA which lies horizontally across an image

Lilly pens $2.2B gene editing pact with Bezos-backed Profluent

Apr 28, 2026 8:40am
Hand with tweezers editing DNA

Intellia races in vivo CRISPR therapy to FDA after phase 3 win

Apr 27, 2026 9:24am
Hand with tweezers editing DNA

Large-scale gene editing tool could power novel genetic meds

Mar 11, 2026 12:00pm
Small bird flying out of a cage

FDA fully releases clinical hold on Intellia CRISPR trials

Mar 2, 2026 10:55am
roundabout

After gene therapy exit, Pfizer licenses Beam gene editing asset

Feb 25, 2026 9:43am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings